“…Such a transcriptomic approach has been used to study the biological effect of CHM in a wide range of conditions, from cancer to fibrosis, and gastrointestinal, neurological, metabolical and immune disorders (Cheng et al, 2008;Efferth et al, 2011;Guo et al, 2010;Kang et al, 2005;Meng et al, 2010;Pan-Hammarström et al, 2006;Sakai et al, 2007;Sun et al, 2008;Watanabe-Fukuda et al, 2009;Wang et al, 2011a,b,c;Yin et al, 2004;Zhuang et al, 2004). An interesting recent development in the use of transcriptomics indicated that this method can be used as a platform for translational research in CHM, by comparing the transcriptomic patterns with genetic databases of drug-altered genes (Lamb, 2007), drug metabolism-related genes and toxicityassociated genes (Hayes et al, 2005).…”